State Of Wyoming Kiniksa Pharmaceuticals, Ltd. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$14.37 - $19.07 $33,654 - $44,661	2,342 New	2,342 $41,000
Q1 2023 May 12, 2023	BUY	$10.7 - $15.79 $11,459 - $16,911	1,071 Added 14.96%	8,231 $88,000
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $23,833 - $35,583	2,087 Added 41.14%	7,160 $107,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $49,512 - $68,028	5,073 New	5,073 $65,000
Q1 2022 May 13, 2022	SELL	$9.3 - $12.37 $1,404 - $1,867	-151 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$10.39 - $15.15 $872 - $1,272	-84 Reduced 35.74%	151 $2,000
Q2 2021 Feb 11, 2022	BUY	$13.22 - $19.09 $3,106 - $4,486	235 New	235 $3,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.